Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic pens contain multiple doses in a single device, allowing patients to adjust their injection over several weeks, but access challenges and cost barriers drive many toward compounded alternatives. Understanding the difference between brand-name delivery systems and customized formulations helps you make an informed choice about your weight management strategy. PlexusDx specializes in precision GLP-1 therapy tailored to your genetic profile and clinical needs.
What Is a Multidose Pen and How Does Ozempic Work?
A multidose pen is an injectable device that contains multiple pre-filled doses of medication, allowing patients to use the same device repeatedly until depleted. Ozempic (semaglutide) comes in multidose pens containing 1.34 mL or 3 mL of solution, with doses ranging from 0.25 mg to 2.4 mg per injection. Patients typically inject once weekly, and the pen automatically dials to the prescribed dose, reducing user error and improving adherence compared to traditional vials.
The multidose design offers convenience for patients who travel or prefer not to manage separate syringes and vials each week. However, Ozempic pens require refrigeration before first use and cost significantly more than many compounded alternatives, with prices often exceeding $900 per month without insurance coverage. For patients without insurance access, the multidose pen format may be financially prohibitive, making compounded GLP-1 options a more accessible choice.
How Compounded GLP-1 Medications Differ From Brand-Name Options
Compounded semaglutide and tirzepatide are produced by licensed 503A compounding pharmacies using pharmaceutical-grade ingredients, then customized to each patient's starting dose and titration schedule. Unlike brand-name pens, compounded medications are priced as flat monthly rates rather than dose-dependent pricing, meaning your dose may need to go up but your price won't. PlexusDx sources all compounded medications exclusively from licensed 503A pharmacies to ensure purity, sterility, and regulatory compliance across all 50 states.
Compounded formulations offer several practical advantages: no insurance requirement, HSA/FSA eligibility, faster access without prior authorization delays, and the ability to start at ultra-low doses for patients sensitive to GLP-1 side effects. The Microdose GLP-1 Protocol at $129 per month allows patients to begin therapy at lower concentrations, reducing nausea and gastrointestinal symptoms during the initial titration phase. Patients can upgrade to standard-strength injections or oral tablets as their tolerance increases, all within PlexusDx's transparent pricing structure.
Why Genetic Testing Optimizes Your GLP-1 Therapy Selection
Not all GLP-1 medications work equally well for every patient because genetic variations in appetite-regulating peptide receptors influence how your body responds to semaglutide, tirzepatide, or dual-compound therapies. PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide genes, including critical variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313, to predict your medication response. This $99 add-on test (available after your first month of treatment) maps over 150 genetic insights that reveal whether you'll benefit most from single-agent therapy, combination protocols, or specialized dosing strategies.
Patients with specific GLP1R variants may experience stronger weight loss with semaglutide, while others with GIPR-dominant pathways show superior results with tirzepatide or GLP-Squared (dual-compound injection combining semaglutide and tirzepatide). The genetic test eliminates months of trial-and-error by identifying your body's natural peptide expression patterns, allowing your clinician to prescribe the right medication at the right starting dose. This precision approach leads to faster weight loss, fewer side effects, and higher long-term adherence compared to standard one-size-fits-all protocols.
PlexusDx Treatment Options: Matching Your Lifestyle and Goals
PlexusDx offers six distinct GLP-1 formulations to accommodate different preferences, tolerances, and efficacy goals. Injections like Compounded Semaglutide (starting at $149/month) and Compounded Tirzepatide (starting at $249/month) deliver maximum bioavailability and predictable weight loss; GLP-Squared Injection ($249/month) combines both compounds for synergistic appetite suppression. For patients who prefer oral delivery, Oral Semaglutide ($249/month), Oral Tirzepatide ($279/month), and GLP-Squared Oral ($369/month) provide equivalent therapeutic benefits without weekly injections, though oral bioavailability requires consistent fasting protocols.
The Microdose GLP-1 Protocol ($129/month) serves as an ideal entry point for GLP-1-naive patients or those with prior side effect concerns, delivering a gentler titration curve that minimizes nausea while preserving weight loss efficacy. Patients can begin their journey with microdose formulations, confirm medication tolerance through the Precision Peptide Genetic Test, and seamlessly transition to full-strength therapies without paying additional initiation fees. No membership costs, no insurance requirements, and HSA/FSA eligibility make PlexusDx accessible to self-pay patients across all income levels and employment statuses.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic a multidose pen, and can I refill it?
Yes, Ozempic comes in multidose pens containing multiple weekly doses that you dial and inject until empty, then discard. The pens cannot be refilled; you must obtain a new prescription and new pen each month, adding administrative burden and cost barriers for many patients seeking continuous weight management therapy.
What's the difference between Ozempic pens and PlexusDx compounded semaglutide?
Ozempic is a brand-name semaglutide pen costing $900+ monthly without insurance, while PlexusDx Compounded Semaglutide starts at $149/month from licensed 503A pharmacies with flat pricing regardless of dose strength. Both contain the same active ingredient, but PlexusDx eliminates insurance barriers, offers faster access, and allows ultramicrodosing for sensitive patients.
How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes your GLP1R, GIPR, FTO, and MC4R variants to predict which medication class your metabolism favors. Patients with GLP1R-dominant pathways typically respond better to semaglutide, while GIPR-dominant variants often show superior weight loss with tirzepatide, allowing your clinician to prescribe the optimal compound from month one.
Are PlexusDx compounded medications FDA-approved?
PlexusDx compounded medications are manufactured by licensed 503A compounding pharmacies using FDA-approved pharmaceutical ingredients, not FDA-approved finished products. This distinction allows personalized dosing and formulations while maintaining the same rigorous quality, sterility, and purity standards as brand-name alternatives.
Can I use HSA or FSA funds to pay for PlexusDx treatment and genetic testing?
Yes, all PlexusDx medications (injections and oral formulations) and the Precision Peptide Genetic Test are HSA/FSA eligible, making personalized GLP-1 therapy more affordable for patients with qualified health savings accounts. This tax-advantaged benefit reduces your out-of-pocket cost and increases accessibility for employed and self-employed individuals.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic for Weight Loss or Diabetes?
Does Wegovy Make You Tired? Understanding Fatigue as a Side Effect